Downregulation of PTEN mediates bleomycin-induced premature senescence in lung cancer cells by suppressing autophagy
Objective
Bleomycin is an important chemotherapeutic drug that activates premature senescence to decrease the tumorigenic process. We aimed to investigate the role of phosphatase and tensin homolog deleted on chromosome ten (PTEN) in bleomycin-induced premature senescence in lung cancer cells.
Methods
Human lung cancer A549 cells were incubated in the presence of different concentrations of bleomycin for 5 days. A lentivirus vector was used to silence the PTEN gene, followed by stimulation with bleomycin (1 µg/mL). Changes were evaluated by senescence-associated β-galactosidase staining, reverse transcription-polymerase chain reaction, and western blot.
Results
Treatment with bleomycin induced premature senescence. PTEN expression was decreased and key downstream molecules in the phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway were gradually activated following bleomycin treatment. Silencing PTEN reduced autophagy and accelerated senescence of A549 cells. Autophagy levels were also increased and senescence markers were reduced after inhibiting mTOR.
Conclusions
Downregulation of PTEN mediates bleomycin-induced premature senescence in lung cancer cells by suppressing autophagy via the PI3K/Akt/mTOR pathway. These findings provide new insights into the potential role of PTEN as a molecular target for cancer chemotherapy.
Top-30
Journals
|
1
2
|
|
|
Biochemical Pharmacology
2 publications, 11.76%
|
|
|
Biomedicine and Pharmacotherapy
2 publications, 11.76%
|
|
|
Antioxidants
1 publication, 5.88%
|
|
|
Frontiers in Oncology
1 publication, 5.88%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 5.88%
|
|
|
Nutrition and Metabolism
1 publication, 5.88%
|
|
|
Ageing Research Reviews
1 publication, 5.88%
|
|
|
Experimental Gerontology
1 publication, 5.88%
|
|
|
Advances in Cancer Research
1 publication, 5.88%
|
|
|
Journal of Thoracic Disease
1 publication, 5.88%
|
|
|
Autophagy
1 publication, 5.88%
|
|
|
Seminars in Cancer Biology
1 publication, 5.88%
|
|
|
Food and Chemical Toxicology
1 publication, 5.88%
|
|
|
Cell Cycle
1 publication, 5.88%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
7
8
9
|
|
|
Elsevier
9 publications, 52.94%
|
|
|
Frontiers Media S.A.
2 publications, 11.76%
|
|
|
Taylor & Francis
2 publications, 11.76%
|
|
|
MDPI
1 publication, 5.88%
|
|
|
Springer Nature
1 publication, 5.88%
|
|
|
AME Publishing Company
1 publication, 5.88%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 5.88%
|
|
|
1
2
3
4
5
6
7
8
9
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.